Pharmaceutical Executive-03-01-2011

Castellani Takes Charge at PhRMA

Boehringer Ingelheim's PICASSO program helps it focus on engaging industry stakeholders to improve patient care

Despite its dimunitive size, the pharmaceutical industry looks to the Netherlands for a world-class medical infrastructure, new standards in innovation, and a closely-knit community of stakeholders

Ferring finds a new approach to communicate its value offering

Ipsen is redefining a standard for success in innovation with its local Dutch affiliate

With an emphasis on short-term objectives rather than long-term goals, pharma is missing a huge opportunity in applying market science to drive adherence

Pharma can be an insular industry, with limited capacity to gaze beyond its own narrow frame of vision

Negative views regarding pharma are on the rise, but vaccines help keep the focus on the positives of innovation

FDA's Sentinel Initiative raises broader questions about tapping patient information and health IT for comparative studies in drug development

The Federal Circuit court continues its trend in tightening the standards for establishing patent damages by leapfrogging a stalled legislative process

Can PhRMA's own business model synch with industry's Pharm Exec takes a closer look at PhRMA's new leadership.